A further updated version of the medicines in practice document reviewing the cardiovascular outcomes associated with SGLT2 inhibitors is
The April 2020 to September 2020 Growth Contrast Tool is now online.
October 2020 reports are now online. These documents are available to our stakeholders only (username and password required).
The latest Price Concession bulletin (formally named NCSO bulletin) based on November 2020 prices is now available online for stakeholder
Our December 2020 Monthly Horizon Scanning Report is now available.
An updated version of the medicines in practice document reviewing the cardiovascular outcomes associated with GLP1 receptor agonists is
The Prescribing Support Team at the RDTC have been developing an Inhaler Carbon Impact Assessment Tool, which aims to provide the carbon
Our new reports 'Top 50 Expenditure' (comprising top 50 BNF sections and drugs) for the period April 2020 to September 2020 are now onlin
A new version of the GLP-1 agonists comparison table is now online which has been updated to include oral semaglutide.